Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

China flag China · Delayed Price · Currency is CNY
5.71
-0.15 (-2.56%)
Apr 30, 2026, 9:55 AM CST
44.19%
Market Cap 6.40B
Revenue (ttm) 2.73B
Net Income (ttm) 26.41M
Shares Out 1.09B
EPS (ttm) 0.02
PE Ratio 239.45
Forward PE n/a
Dividend 0.10 (1.59%)
Ex-Dividend Date Jun 12, 2025
Volume 31,158,500
Average Volume 164,473,446
Open 5.87
Previous Close 5.86
Day's Range 5.70 - 5.94
52-Week Range 3.68 - 8.44
Beta -0.03
RSI 50.01
Earnings Date Apr 25, 2026

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation prepar... [Read more]

Sector Healthcare
Founded 1939
Employees 2,884
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600488
Full Company Profile

Financial Performance

In 2025, SHA:600488's revenue was 2.91 billion, a decrease of -9.56% compared to the previous year's 3.22 billion. Earnings were 70.56 million, a decrease of -47.12%.

Financial Statements

News

There is no news available yet.